This opens the door to a new era of oral small molecule therapies that target the well-validated GLP-1R pathway for metabolic health
If these symptoms become so severe that they significantly affect your daily life or ability to eat regularly, then let your provider know
Mounjaro is FDA- approved for managing Type 2 diabetes, while Zepbound targets obesity, showcasing their versatility in addressing metabolic health issues
doi: 10.1016/j.neuron.2011.02.016, 79 KhanR.DotyR
high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, heart disease, knee osteoarthritis, asthma, chronic obstructive pulmonary disease, non-alcoholic fatty liver disease, polycystic ovarian syndrome, or coronary artery disease)
Appointment length varies, but a typical visit lasts about 45 to 60 minutes from check-in to completion